JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, vol.29, no.20, pp.3395-3399, 2016 (SCI-Expanded)
Objective: To evaluate the clinical significance of vaginal bleeding in pregnant women between 14th and 22th gestational weeks.Methods: This retrospective case-control study was conducted between September 2010 and December 2013. Two-hundred nineteen pregnant women with vaginal bleeding between 14th and 22th gestational weeks were compared with 325 pregnant women without vaginal bleeding for their maternal and early neonatal outcomes.Results: Mean gestational age and birth weight of study group were significantly different from those of the control group respectively (37.92.8 versus 38.9 +/- 1.4 and 3071 +/- 710 versus 3349 +/- 446 for groups p<0.001). Vaginal bleeding between 14th and 22th gestational weeks had increased risk of having preterm birth (PB) and preterm premature rupture of membranes (PPROM) (OR: 10.8, 95% CI: [4.5-26.1]; OR: 12.0, 95% CI: [3.5-40.6], respectively). Gestational diabetes mellitus (GDM) and polyhydramnios ratio in the study group was significantly higher than the control respectively (4.1% versus 1.2%, p=0.031; 1.9% versus 0%, p=0.025).Conclusion: Pregnant women with vaginal bleeding was a significantly risk factor for PB, PPROM, GDM, and polyhydramnios. Consequently, these pregnancies should be closely followed up for maternal and fetus complications.